Navigation Links
BellBrook Labs Awarded NIH Grant to Develop a High Throughput cGAS Assay for Cancer and Autoimmune Disease Drug Discovery
Date:6/14/2017

The National Institutes of General Medical Sciences (NGMS) has awarded a Phase I $288,000 Small Business Innovative Research (SBIR) grant to BellBrook Labs, LLC for the commercialization of an innovative high throughput screening (HTS) assay for detecting cyclic GMP-AMP(cGAMP) the product of the cGAMP synthase (cGAS) enzyme.

cGAS is a novel target shown to have implications in immuno-oncology and autoimmune diseases. As foreign DNA enters the cell, cGAS detects the DNA and produces cGAMP, which acts as an agonist for the STING (stimulator of interferon genes) receptor to induce a type I interferon response. Researchers have shown that regulating cGAS activity could help control this immune response with therapeutic benefit for interferon-driven autoimmune diseases such as lupus. Progress discovering small molecule cGAS modulators have been slowed by the lack of HTS-compatible assays.

BellBrook has leveraged its proprietary Transcreener® platform to directly measure cGAMP in a homogeneous immunoassay format with fluorescent readouts. Direct detection reduces the potential for interference in HTS and allows kinetic methods such as determination of residence times for more effective lead optimization early in discovery. The Transcreener cGAS Assay will enable screening of diverse small molecules for an emerging target in autoimmunity and immuno-oncology, accelerating discovery of first-in-class drugs for debilitating diseases.

About BellBrook Labs:

BellBrook Labs is dedicated to accelerating drug discovery and biological research by providing innovative high throughput screening solutions. Transcreener® is a universal, homogeneous biochemical assay platform based on detection of nucleotides that makes it easy to screen thousands of different enzymes. These include validated targets like kinases and phosphodiesterases, as well as emerging targets like ATPases, GTPases, methyltransferases, and glycosyltransferases. Detection reagents and drug discovery services from BellBrook Labs help researchers progress toward more effective therapies for cancer and other debilitating diseases.

Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R43GM123833.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Read the full story at http://www.prweb.com/releases/cGAS/Assay/prweb14421391.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. BellBrook Labs Webinar: Development of Ectonucleotidase Assay Methods Using the Transcreener® HTS Assay Platform
2. Top Accolades Awarded to Angry Citizen, Ecocat, Medesk and WESTUDY.IN At Challenge Cup Moscow
3. Puritan Medical Products Awarded Two New Flocked Swab Patents in Australia
4. Borrego Health Awarded $816,667 to Open Clinics in Anza and San Jacinto
5. Team of Chicago hospitals awarded grant to accelerate stroke research, treatments
6. Icahn School of Medicine at Mount Sinai awarded $2.7 million from NIH to investigate novel therapy for eczema
7. Steven Winter Associates, Inc. Awarded U.S. EPA's 2013 Indoor airPLUS Leader Award
8. Advanced Medical Awarded Recertification by the Joint Commission
9. Arminco, Inc. Awarded Contract to Design Alexandria Dental Office of Parker-Gray Pediatric Dental Care
10. Aequor Technologies Awarded Managed Services Contract to Provide Hardware Configuration and Deployment for Global Pharmaceutical Corporation
11. Kessler Foundation awarded grant to study self-generated learning in multiple sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2018)... ... August 14, 2018 , ... Eagle Merchant ... a leading provider of residential and commercial recreational surfacing products across the country. ... with products used across a wide range of markets and customers. Founded in ...
(Date:8/11/2018)... ... ... Johns Hopkins All Children’s Hospital will make a broader commitment to ensuring ... perspective on care. At its core, this perspective focuses on ways to improve health ... or setting at the right cost. Mark Douglas "Doug" Baker, M.D., will focus on ...
(Date:8/9/2018)... SEATTLE (PRWEB) , ... August 09, 2018 , ... Lyme ... cases reported per year skyrocketing to an estimated 329,000 – a 25-fold increase since ... Trends™ , Lyme disease can be found all 50 states and the District of ...
(Date:8/9/2018)... ... August 09, 2018 , ... Thanks to the generosity of ... distributors, customers, and employees, the newly established Isagenix Legacy Foundation raised ... goal. 100 percent of the donations will fund grants to nonprofit organizations that ...
(Date:8/7/2018)... ... August 07, 2018 , ... The American ... selected to receive the 2018 Board of Directors Student Scholarship . The ... of psychiatric-mental health nursing and develop the next generation of leaders in the ...
Breaking Medicine News(10 mins):
(Date:8/7/2018)... ... August 07, 2018 , ... ... the role of Sanarus Technologies President, effective immediately. Mr. Stark will lead ... sales experience in medical device toward finding new and innovative ways to ...
(Date:8/3/2018)... ... August 03, 2018 , ... LifeWIRE’s ... ACT patents list of the 5,000-strong association of app companies and information technology ... Self-Management Compliance and Notification Method System and Computer Program Product” and subsequent patents ...
(Date:8/2/2018)... ... August 02, 2018 , ... What: The Wharton School is pleased to ... will allow up to five business reporters who cover aspects of public policy to ... year. Each funding opportunity covers the cost of tuition, course materials, most group ...
Breaking Medicine Technology: